Biome Australia Limited (BIO.AX)
- Previous Close
0.3200 - Open
0.3250 - Bid 0.3200 x --
- Ask 0.3300 x --
- Day's Range
0.3250 - 0.3350 - 52 Week Range
0.0600 - 0.4350 - Volume
119,588 - Avg. Volume
464,984 - Market Cap (intraday)
69.169M - Beta (5Y Monthly) 1.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Biome Australia Limited develops, commercializes, and markets various live biotherapeutics and complimentary medicines in Australia and internationally. It provides live biotherapeutic products under the Activated Probiotics brand; organic nutraceutical products under the Activated Nutrients brand; and sports performance and recovery products under the Activated X Performance brand. The company markets its products through community pharmacies, independent health practitioners, and health professionals. Biome Australia Limited was incorporated in 2018 and is based in Cremorne, Australia.
www.biomeaustralia.comRelated News
Performance Overview: BIO.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIO.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIO.AX
Valuation Measures
Market Cap
69.17M
Enterprise Value
68.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.67
Price/Book (mrq)
32.21
Enterprise Value/Revenue
6.95
Enterprise Value/EBITDA
-27.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-29.03%
Return on Assets (ttm)
-28.55%
Return on Equity (ttm)
-82.81%
Revenue (ttm)
9.87M
Net Income Avi to Common (ttm)
-2.86M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.02M
Total Debt/Equity (mrq)
67.56%
Levered Free Cash Flow (ttm)
-2.27M
Company Insights: BIO.AX
BIO.AX does not have Company Insights